Heart Failure opTIMISM

Dear Sirs,
due to the epidemiological threat of SARS-CoV-2 coronavirus and changing situation in Europe it is currently very difficult to assess if it is possible and safe to run Heart Failure opTIMISM Conference 2020 as scheduled. We have discussed the situation with our partners and decided to postpone the event to a later date. We will inform you about the new date in the near future. Please follow the messages posted at our webpage.

Prof. Piotr Ponikowski and Adrian Szulczyński

Project directors

Ladies and Gentlemen!

The second edition of Cardiology Innovations Days under the auspices of Polish Cardiac Society covers this year international conference Heart Failure opTIMISM which focuses on health condition of patients with heart failure in aspects of TherapIes, MonItoring and Self Management.

As it is our main theme, international and interdisciplinary teams of professionals will analyze the possibilities of therapy and applying innovations, as well as methods for monitoring and analyzing data used by patients for self-monitoring since it has significant influence on their behaviour.

During the conference (in the part dedicated only to doctors involved in cardiology) we shall also discuss new therapeutical, technological, and logistic solutions that are aimed at ensuring better quality in the treatment management of patients with heart failure. We firmly believe that an open, professional and interdisciplinary exchange of experience and confrontation of visionary ideas will give beginning to solutions that will give hope for increased effectiveness in the prevention and treatment of heart failure which is considered to be an epidemic of the 21st century.

The conference programme includes sessions on pharmacological novelties in the prevention and treatment of heart failure – taking into account the Polish experience connected with coordinated care for patients who had suffered a heart infarction, sessions on modern devices and mechanical support for heart failure patients, as well as sessions on telemedicine, hybrid comprehensive tele-rehabilitation and innovative solutions in the field of e-health.

We would like to encourage you to participate in this unique international event so that we can work together to develop an optimistic concept for a better health perspective for patients with heart failure.

Prof. Piotr Ponikowski and Adrian Szulczyński

Project directors

PROGRAM

14th May 2019

Venue: Ibis Styles, plac Konstytucji 3 Maja 3, Wrocław - Conference room B

14.00–16.00

Expert systems for predicting the health condition of a patient with heart failure

The final presentations of Cardiology Innovations Hackathon 2019

17.30-19.00

Opening Ceremony

Honorary Lectures

Visceral feedbacks (patho)physiology in health and heart failure

M. Piepoli (IT)
Chief of the Heart Failure Unit, Cardiology Department – Guglielmo da Saliceto Polichirurgico Hospital | Chair of the Clinical Science Section of the Heart Failure Association | Editor in Chief of the European Journal of Preventive Cardiology

Advances in Advanced Heart Disease

M. Mehra (US)
The William Harvey Distinguished Chair in Advanced Cardiovascular Medicine | Executive Director, Center for Advanced Heart Disease | Professor of Medicine, Harvard Medical School, Boston

19:00

Networking reception

15th May 2019

8.30-12.40	Session: Novel pharmacological and device therapies in Heart Failure Pharmacology Chair: P. Seferovic (RS), P. Ponikowski (PL)
8.30-8.45	New glucose-lowering drugs – unexpected indication for Heart Failure? P. Seferovic (RS)
8.45-9.00	Best options to prevent Heart Failure: a. optimal management of hypertension K. Narkiewicz (PL)
9.00-9.15	b. coordinated care in post-MI patients: Polish experience P. Jankowski (PL)
9.15-9.30	c. inflammation revisited – Canakinumab G. Rosano (IT)
9.30-9.45	Growing evidence with sacubitril/valsartan for broader indications? P. Ponikowski (PL)
9.45-10.00	What else in the pharmacological pipeline? J. Cleland (UK)
10.00-10.10	Discussion
10.10-10.30	Coffee break
10.30-12.40	Devices & Telemonitoring Chair: J. Cleland (UK)
10.30-11.00	Mechanical circulatory support: 2019 state of the art M. Mehra (US)
11.00-11.30	Telemedicine for Heart Failure patients: 2019 state of the art F. Koehler (D)
11.30-11.45	Device-based decongestion TARGET Study – Polish experience R. Zymlinski (PL)
11.45-12.00	Cardiac Contractility Modulation – Current Indications D. Jagielski (PL)
12.00-12.15	Inter-atrial shunts F. Kleber (D)
12.15-12.30	Phrenic nerve stimulation to treat central sleep apnea P. Ponikowski (PL)
12.30-12.40	Discussion
12.40-13.10	Lunch break
13.10-14.05	Session: Valve interventions in Heart Failure Chair: K. Reczuch (PL), S. von Bardeleben (D)
13.10-13.25	TAVI for patients with Heart Failure – any evidence? A. Witkowski (PL)
13.25-13.40	Trans-catheter therapies for functional mitral regurgitation: 2019 state of the art S. von Bardeleben (D)
13.40-13.55	How to handle functional tricuspid valve regurgitation? G. Nickenig (D)
13.55-14.05	Discussion
14.05-15.30	Session: Telemedicine, Monitoring and Self-Care management Chair: W. Banasiak, K. Kozak
14.05-14.20	Telemedicine – Polish experience: a. AMULET trial P. Krzesiński (PL)
14.20-14.35	b. hybrid comprehensive tele-rehabilitation – TELEREH-HF study E. Piotrowicz (PL)
14.35-14.50	Evidence for CardioMEMS G. Rosano (IT)
14.50-15.05	Big-data handling – challenge for the near future K. Kozak (D)
15.05-15.15	Discussion